Thinking of a Career in Emergency Management?
- BY Nicole Pelette
Malaria Consortium is one of the world's leading non-profit organisations dedicated to the comprehensive control of malaria and other communicable diseases in Africa and Southeast Asia. Malaria Consortium works with communities, government and non-government agencies, academic institutions, and local and international organisations, to ensure good evidence supports the delivery of effective services, providing technical support for monitoring and evaluation of programmes and activities for evidence-based decision-making and strategic planning. The organisation works to improve not only the health of the individual but also the capacity of national health systems, which helps relieve poverty and support improved economic prosperity. Malaria Consortium is a global leader in the prevention, diagnosis and treatment of malaria, the control of neglected tropical diseases and the promotion of child health.
Malaria Consortium is developing a proposal in response to the Call for Proposals: Intermittent Preventive Treatment in infants issued on 4 th December 2019 by Unitaid and will be the lead of a consortium. Under this Call, Unitaid is soliciting proposals for implementation pilots for IPTi delivery to catalyse country uptake and inform future policy and guidelines. The aim of the pilots should be to accelerate the adoption and scale-up of IPTi in moderate-to-high transmission settings. In October 2019, WHO held a Technical Consultation to Review the Role of Drugs in Malaria Prevention for People Living in Endemic Settings. Participants encouraged increased IPTi scale-up and reiterated that IPTi should be pursued with a sense of urgency. There was agreement that a more flexible approach to IPTi implementation could engender adoption by countries. It was therefore recommended that adaptations of the current IPTi recommendations be tested through pilot implementation with robust evaluation to assess impact, operational feasibility and cost-effectiveness.
As described in Unitaid’s Malaria Disease Narrative 2019, accelerated adoption and scale-up of malaria chemoprevention, including IPTi, represents a near-term opportunity that would support efforts to reignite progress in high-burden countries.
Purpose of the consultancy
The purpose of the consultancy is to lead the writing of the proposal according to the requirements and templates specified in the Donor guidelines with inputs and contributions from the Malaria consortium and its partners.
The successful candidate will be working closely with designated staff of Malaria Consortium and its key partners in this bid.
This is a deliverable-based contract and subject to submission of the proposal before the deadline. The consultant will be responsible for developing the following deliverables working with designated staff from the Malaria Consortium and partner organisations:
These will be developed in accordance with the instructions and requirements detailed in the Call for proposals and with subsequent information from the donor. The deliverables will
be based on the timely and quality provision of agreed inputs from the designated bid development team. The consultant will maintain proactive follow-up with the bid development team and escalate any issues with the assigned point of escalation. All deliverables will be signed off by the Technical Director
Key tasks and responsibilities
Work with the Bid Manager to develop a detailed proposal writing and review schedule to address key proposal requirements:
Develop an activity plan:
In order to respond to the requirements of the call, Malaria Consortium is presently identifying and forming agreements with partner organisations who will contribute to the bid development process
A bid team will be put in place to coordinate and work closely with the consultant. The bid team will include: A bid manager will oversee the bid process, a technical lead, a M&E expert and a budget expert. Coordination will also be required with partners’ focal teams. The consultant will maintain proactive follow-up with the bid development team and escalate any issues with the assigned point of escalation within two working days of first occurrence. The Business Development team (UK based) will provide administrative support. Indicative Schedule A timeline detailing drafting and review phases will be developed by the Malaria Consortium bid team.
Qualification and experience
Duration and availability
This is for one full time equivalent of up to 30 days, to be drawn down as necessary between 27 January and 10 March 2020. All final deliverables shall be submitted to the BD team as agreed in a schedule to be determined once the RFP is issued. The consultancy fee will cover 1 FTE per day.
The consultant will be home based and is expected to travel to the UK office of Malaria Consortium in London for approximately 10 working days.
How to apply
To apply, please submit an updated CV, including your fee rate, to email@example.com. This tender will be published for two weeks but applications will be reviewed on a rolling basis. Note that we will require you to have professional indemnity insurance.